Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer Meeting Abstract
| Authors: | Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; Modi, S.; Gupta, R.; Traina, T. A. |
| Abstract Title: | Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 16s |
| Language: | English |
| ACCESSION: | WOS:000442916000041 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.531 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 531 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
